Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maria do Socorro de Mendonça Cavalcanti is active.

Publication


Featured researches published by Maria do Socorro de Mendonça Cavalcanti.


Bioresource Technology | 2003

Isolation of a trypsin inhibitor from Echinodorus paniculatus seeds by affinity chromatography on immobilized Cratylia mollis isolectins

P.M.G Paiva; A.F Souza; Maria Luiza Vilela Oliva; J.F Kennedy; Maria do Socorro de Mendonça Cavalcanti; Luana Cassandra Breitenbach Barroso Coelho; Claudio A. M. Sampaio

A highly purified trypsin inhibitor was obtained from Echinodorus paniculatus when an extract prepared from E. paniculatus seed flour (25 gl(-1), with 0.1 M ammonium acetate buffer, pH 8.3, under agitation for 6 min at 28 degrees C) was chromatographed on Sephadex G-25 (12 mlh(-1)), followed by affinity chromatography on immobilized Cratylia mollis isolectins (Cra Iso 1,2,3-Sepharose). The column chromatography was performed at 24 degrees C; the matrix was washed (30 mlh(-1)) with 0.1 M sodium phosphate buffer, pH 7.4 or with the same buffer containing 0.2 M glucose, followed by application of inhibitor sample and elution with 0.015 M sodium borate buffer, pH 7.4, or 1.0 M NaCl. A purified fraction of inhibitor was obtained by gel filtration chromatography (GF-450/HPLC column). Trypsin inhibitory activity was eliminated when the inhibitor was treated with metaperiodate showing that the carbohydrate moiety was important for trypsin inhibition. Binding of inhibitor was also evaluated on immobilized concanavalin A (Con A-Sepharose) using previously described chromatographic conditions with results similar to Cra Iso 1,2,3-Sepharose chromatography.


Cytokine | 2013

High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.

D.C.B.L. Aroucha; R.F. do Carmo; Patrícia Moura; J.L.A. Silva; L.R.S. Vasconcelos; Maria do Socorro de Mendonça Cavalcanti; Maria Tereza Cartaxo Muniz; M.L. Aroucha; E.R.F. Siqueira; G.G.O.M. Cahú; Leila Maria Moreira Beltrão Pereira; Maria Rosãngela C.D. Coêlho

Hepatitis C virus (HCV) is the main cause of chronic liver disease, cirrhosis and hepatocellular carcinoma (HCC) worldwide. The risk for the development of HCC increases with the severity of liver inflammation and fibrosis. The hepatic inflammation caused by HCV involves host regulatory immune response, which is mediated by cytokines with anti-viral role upon the interaction of viral polypeptides with innate and adaptive immunity. Two cytokines; tumor necrosis factor-α (TNF-α) and interleukin-10 (IL-10) play key roles in the regulation of cellular immune response in HCV infection. The aim of the present study was to determine the levels of IL-10 and TNF-α, as well as the ratio of TNF-α and IL-10 serum levels in patients with HCV and HCC caused by HCV (HCC-HCV). The study included 173 patients with chronic HCV. TNF-α and IL-10 serum levels were measured by ELISA (R&D Systems, Inc.). In the present study, 54 patients presented liver mild fibrosis, 68 had severe fibrosis and 51 patients had HCC. After adjustment in the multivariate regression analysis, the following variables remained significantly associated with HCC-HCV occurrence: diabetes (p=0.012 OR 10.44 CI 1.66-65.60), IL-10 lower levels (p<0.0001 OR 0.83 CI 0.78-0.89) and TNF-α higher levels (p<0.0001 OR 1.19 CI 1.11-1.28). Individuals with HCC presented higher TNF-α/IL-10 ratio than those with fibrosis grade F4, F3 or F0+F1+F2 (p=0.0003, p<0.0001, p<0.0001, respectively). Patients with HCC were associated to higher index TNF-α/IL-10 ratio, suggesting that the unbalanced production of these cytokines may represent progression to the liver disease severity in HCV infected patients.


Micron | 2013

Ultrastructural characterization of the hemocytes of Lasiodora sp. (Koch, 1850) (Araneae: Theraphosidae).

Tatiana Soares; Marília Gabriela dos Santos Cavalcanti; Felipe Roberto Borba Ferreira; Maria do Socorro de Mendonça Cavalcanti; Luiz Carlos Alves; Fábio André Brayner; Patrícia Maria Guedes Paiva

This paper is the first descriptive review of hemolymph cell types in the circulation of the tarantula spider Lasiodora sp. These animals are more long-lived than other arthropods, and may live for approximately twenty years. Such remarkable longevity may result from a highly successful immune system, which in turn is directly correlated with hemocyte function. Since the literature on the genus Lasiodora sp. is limited, the main goal of the present study was to identify the different cell types by optical and transmission microscope. Six hemocyte types were characterized and called prohemocyte, granulocyte type I, granulocyte type II, spherulocyte, oenocytoid and plasmatocyte. Prohemocytes presented a large nucleus, elongated granulocytes type I showed the nucleus with the same cell format, elliptical granulocytes type II showed the central nucleus of identical shape, spherulocytes exhibited the nucleus filling almost the whole cell, oval oenocytoids showed eccentric nucleus and less dense cytoplasm, and irregular plasmatocytes showed a nucleus and no granules in cytoplasm. These polymorphic granulocytes presented a round, elongated, elliptical, oval or irregular profile with large and varied numbers of granules, except for plasmatocytes, that were agranular. Different densities and different concentrations of these granules were found at the periphery of the cell. The possible reasons and implications of differences and similarities between arthropods hemocytes are discussed. It can be concluded that there are six cell types in Lasiodora sp. This study is of the first step in the elucidation of the role these cells play in the circulatory and immune system in spiders.


International Journal of Infectious Diseases | 2011

Mannose-binding lectin serum levels in patients with leprosy are influenced by age and MBL2 genotypes

Luydson Richardson Silva Vasconcelos; Juliana Pereira Lopes Fonseca; Rodrigo Feliciano do Carmo; Taciana Furtado de Mendonça; Valéria Rêgo Alves Pereira; Norma Lucena-Silva; Leila Maria Moreira Beltrão Pereira; Patrícia Moura; Maria do Socorro de Mendonça Cavalcanti

BACKGROUND Mannose-binding lectin (MBL) activates the complement system promoting opsonophagocytosis, which could represent an advantage for Mycobacterium leprae, an intracellular pathogen. Therefore, a single nucleotide polymorphism (SNP) in the MBL2 gene associated with low levels of MBL could confer protection against the development of leprosy disease. METHODS In this study, we investigated SNPs of the MBL2 gene and MBL levels in 228 Brazilian leprosy patients and 232 controls. RESULTS There were no differences in the frequencies of variant genotypes and haplotypes of MBL2 between patients and controls, or between the different clinical forms of leprosy. In the group of patients with a genotype for high expression of MBL2, those aged>40 years had decreased MBL levels compared to patients aged ≤ 40 years (p = 0.037). CONCLUSION Our results demonstrate that age could influence the phenotype of MBL2, but no evidence was found for an association of MBL2 polymorphism with susceptibility to leprosy or its clinical forms.


Arquivos Brasileiros De Endocrinologia E Metabologia | 2006

Avaliação da relação entre o polimorfismo C677T no gene para MTHFR e a concentração plasmática de homocisteína na doença arterial coronariana

Maria Tereza Cartaxo Muniz; Erika Rabelo Forte de Siqueira; Rosana A. Fonseca; Vânia D'Almeida; Júlia K. Hotta; José Ernesto dos Santos; Maria do Socorro de Mendonça Cavalcanti; Claudio A. M. Sampaio

OBJECTIVE: The aim of this study is to determine the prevalence of C677T methylenetetrahydrofolate reductase (MTHFR) polymorphism and correlate it with plasma homocysteine levels in coronary artery disease (CAD). METHODS: Ninety-three patients with documented CAD from Hospital Universitario Oswaldo Cruz (Recife, PE, Brazil) and 108 healthy controls were evaluated. Homocysteine and folate levels were determined by HPLC and chemoluminescence, respectively, and lipid profile was considered. Genotyping was done by RFLP/PCR. RESULTS: The groups were homogeneous for the C677T polymorphisms. The homocysteine level in cases (11.7 µmol/L) was statistically different from that observed in controls (8.84 µmol/L, p< 0.05). It was also observed that 72% of the patients had homocysteine values above12 µmol/L while the control group presented only 32% in this range. There was no relationship between homozigosity for the C677T polymorphism and the homocysteine level (p= 0.634). We noticed statistical differences between folate levels from patients and controls (6.22 and 7.69 ng/dL, p< 0.05, respectively). However, there was no correlation between homocysteine and folate concentrations in the entire group (r= -0.202). Comparing cases and controls, the odds ratio (OR) when homocysteine is high and folate is low was OR= 11.9; CI 95%= 4.16-34.42, p< 0.01. CONCLUSION: A lack of correlation between C677T mutation and homocysteine level suggests that environmental factors and others genetic factors seem to exert more influence on homocysteine level in this population.


Journal of Medical Virology | 2016

TNF-α and IL-10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals

D. Aroucha; Rodrigo Feliciano do Carmo; Luydson Richardson Silva Vasconcelos; Raul Lima; Taciana Furtado de Mendonça; Lucia Elena Arnez; Maria do Socorro de Mendonça Cavalcanti; Maria Tereza Cartaxo Muniz; Marcílio L Aroucha; Erika Rabelo Forte de Siqueira; Luciano Pereira; Patrícia Moura; Leila Maria Moreira Beltrão Pereira; Maria Rosãngela C.D. Coêlho

Hepatitis C virus (HCV) is the major cause of hepatocellular carcinoma (HCC). The risk to develop HCC increases with the severity of liver inflammation and hepatic fibrosis. It is believed that a balance between the releases of pro‐ and anti‐inflammatory cytokines will determine the clinical course of HCV and the risk to develop HCC. The inteleukin‐10 (IL‐10) and the tumor necrosis factor alpha (TNF‐α) play key roles in the Th1 and Th2 balance during the inflammatory response against HCV. The aim of the present study was to investigate the association between polymorphisms in TNF‐α ‐308 G>A (rs1800629), IL‐10 ‐1082 G>A (rs1800896) and ‐819/‐592 (rs1800871/rs1800872) with HCC risk in individuals with HCV. The present study evaluated 388 chronic HCV patients. Polymorphisms were determined by real‐time PCR. Diplotypes associated with low IL‐10 production and the TNF‐α GG genotype were significantly associated with HCC occurrence after multivariate logistic regression analysis (P = 0.027 and P = 0.029, respectively). Additionally, the IL‐10 ‐819 (‐592) TT (AA) genotype was significantly associated with multiple nodules and HCC severity according to BCLC staging (P = 0.044 and P = 0.025, respectively). Patients carrying low production haplotypes of IL‐10 and the TNF‐α GG genotype have higher risk to develop HCC. J. Med. Virol. 88:1587–1595, 2016.


Journal of Viral Hepatitis | 2016

Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV

Rodrigo Feliciano do Carmo; D. Aroucha; Luydson Richardson Silva Vasconcelos; Leila Maria Moreira Beltrão Pereira; Patrícia Moura; Maria do Socorro de Mendonça Cavalcanti

Hepatitis C virus (HCV) is the main cause of chronic liver disease, cirrhosis and hepatocellular carcinoma (HCC) worldwide. The risk to develop HCC increases with the severity of liver inflammation and fibrosis. Long pentraxin 3 (PTX3) is a soluble pattern‐recognition receptor produced by phagocytes and nonimmune cells at sites of inflammation or injury. The aim of the present study was to determine the association of PTX3 polymorphisms and its plasma levels with HCC occurrence among patients with HCV. Samples from 524 patients with chronic hepatitis C were evaluated in this study. Two polymorphisms (rs1840680 and rs2305619) in the PTX3 gene were determined by real‐time PCR. PTX3 plasma levels were measured by Enzyme‐linked Immunosorbent Assay (ELISA). Our data show a significant association between PTX3 polymorphisms and HCC occurrence in univariate and multivariate analysis (P = 0.024). Patients with HCC had higher PTX3 plasma levels compared to individuals with mild or severe fibrosis (P < 0.0001 and P = 0.002, respectively). In addition, PTX3 rs2305619 polymorphism and plasma levels were correlated with Child‐Pugh scores B and C in HCC individuals. PTX3 seems to be a risk factor for HCC occurrence in chronic hepatitis C. This is the first study that evaluates PTX3 in the context of hepatitis C.


Cytokine | 2017

Role of Interleukin-22 in chronic liver injury.

Rodrigo Feliciano do Carmo; Maria do Socorro de Mendonça Cavalcanti; Patrícia Moura

HighlightsIL‐22 protects against hepatocyte damage in several liver injury models.IL‐22 stimulates proliferation of liver progenitor cells.IL‐22 may have pathological effects.IL‐22 role depends on duration of infection and intrahepatic microenviroment. Abstract Liver fibrosis is the result of an exacerbated wound‐healing response associated with chronic liver injury. Advanced liver fibrosis results in cirrhosis, liver failure, and portal hypertension and frequently requires liver transplantation. The host immune response has an important role driving fibrosis deposition by activating hepatic stellate cells (HSCs). Interleukin‐22 (IL‐22) is a cytokine that plays a key role in promoting antimicrobial immunity and tissue repair at barrier surfaces. Data from literature suggest that IL‐22 has a protective role in the liver by reducing fibrosis in some pathological conditions, however the results are contradictory. This review highlights current knowledge of IL‐22’ role in chronic liver injury, as well as its therapeutic potential for the treatment of chronic liver injury.


Human Immunology | 2014

Myeloperoxidase gene polymorphism predicts fibrosis severity in women with hepatitis C

Rodrigo Feliciano do Carmo; Luydson Richardson Silva Vasconcelos; Taciana Furtado de Mendonça; Maria do Socorro de Mendonça Cavalcanti; Leila Maria Moreira Beltrão Pereira; Patrícia Moura

Oxidative stress plays an important role on liver fibrosis progression in the course of hepatitis C virus (HCV) infection. Myeloperoxidase (MPO) is an enzyme released by neutrophils and macrophages, responsible for generating hypochlorous acid and reactive oxygen species (ROS) that may lead to liver injury in HCV infection. On the other hand, antioxidant enzymes such as manganese superoxide dismutase (SOD) controls ROS-mediated damage. The aim of the present study was to investigate the influence of MPO G-463A and SOD2 Ala16Val polymorphisms in the severity of liver fibrosis in individuals with chronic HCV infection. The present study included 270 patients with chronic HCV recruited from the Gastrohepatology Service of the Oswaldo Cruz University Hospital/Liver Institute of Pernambuco (Recife, Northeastern Brazil). All patients underwent liver biopsy, which was classified according METAVIR score. The SNPs were determined by real-time PCR. After multivariate analysis adjustment, the GG genotype of MPO and the presence of metabolic syndrome were independently associated with fibrosis severity in women (P = 0.025 OR 2.25 CI 1.10-4.59 and P = 0.032 OR 2.32 CI 1.07-5.01, respectively). The presence of the GG genotype seems to be a risk factor for fibrosis severity in women with HCV.


Annals of Human Genetics | 2016

Association of Catalase and Glutathione Peroxidase 1 Polymorphisms with Chronic Hepatitis C Outcome.

Vanessa C.S.D. Sousa; Rodrigo Feliciano do Carmo; Luydson Richardson Silva Vasconcelos; D. Aroucha; Leila Maria Moreira Beltrão Pereira; Patrícia Moura; Maria do Socorro de Mendonça Cavalcanti

The hepatic damage caused by hepatitis C virus (HCV) infection is associated with the host immune response and viral regulatory factors. Catalase (CAT) and glutathione peroxidase 1 (GPX1) are antioxidant enzymes located in the peroxisomes and mitochondria, respectively, and are responsible for the control of intracellular hydrogen peroxide levels. Polymorphisms in CAT (C‐262T) and GPX1 (Pro198Leu) are correlated with serum levels and enzyme activity. This study aimed to investigate the association of genetic polymorphisms of CAT C‐262T (rs1001179) and GPX1 Pro198Leu (rs1050450) with different stages of liver fibrosis and development of hepatocellular carcinoma (HCC). This study included 445 patients with chronic hepatitis C, of whom 139 patients had mild fibrosis (F0‐F1), 200 had moderate/severe fibrosis (F2‐F4), and 106 had HCC. Genotyping of SNPs was performed by real‐time PCR using TaqMan probes. The Pro/Pro genotype of GPX1 was significantly associated with fibrosis severity, HCC, Child Pugh score, and BCLC staging. Additionally, patients carrying both CT+TT genotypes in the CAT gene and the Pro/Pro genotype in the GPX1 gene had higher risk for developing moderate/severe fibrosis or HCC (p = 0.009, OR 2.40 and p = 0.002, OR 3.56, respectively). CAT and GPX1 polymorphisms may be implicated in the severity of liver fibrosis and HCC caused by HCV.

Collaboration


Dive into the Maria do Socorro de Mendonça Cavalcanti's collaboration.

Top Co-Authors

Avatar

Patrícia Moura

Universidade de Pernambuco

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Taciana Furtado de Mendonça

Universidade Federal Rural de Pernambuco

View shared research outputs
Top Co-Authors

Avatar

Claudio A. M. Sampaio

Federal University of São Paulo

View shared research outputs
Top Co-Authors

Avatar

D. Aroucha

Universidade de Pernambuco

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge